11-Sep-2026
PetMeds Announces First Quarter Financial Results
Globe Newswire (Thu, 13-Aug 4:05 PM ET)
Globe Newswire (Thu, 30-Jul 8:00 AM ET)
Globe Newswire (Thu, 23-Jul 8:00 AM ET)
PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform
Globe Newswire (Tue, 14-Jul 8:00 AM ET)
Market Chameleon (Tue, 30-Jun 6:33 AM ET)
Globe Newswire (Tue, 30-Jun 9:15 AM ET)
Market Chameleon (Mon, 29-Jun 5:52 AM ET)
SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash
Globe Newswire (Mon, 29-Jun 7:08 AM ET)
PetMeds Unveils Wellness-Focused Holiday Collection Aimed at Health-Conscious Pet Parents
Market Chameleon (Thu, 11-Dec 4:53 AM ET)
PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.
Petmed Express trades on the NASDAQ stock market under the symbol PETS.
As of September 11, 2026, PETS stock price declined to $1.65 with 36,977 million shares trading.
PETS has a beta of 1.41, meaning it tends to be more sensitive to market movements. PETS has a correlation of 0.04 to the broad based SPY ETF.
PETS has a market cap of $35.77 million. This is considered a Sub-Micro Cap stock.
Last quarter Petmed Express reported $41 million in Revenue and -$.28 earnings per share. This beat revenue expectation by $31 million and missed earnings estimates by -$.40.
In the last 3 years, PETS traded as high as $11.80 and as low as $1.57.
The top ETF exchange traded funds that PETS belongs to (by Net Assets): VTI, VXF, BSVO, FSCC, AVSC.
PETS has underperformed the market in the last year with a price return of -41.7% while the SPY ETF gained +17.4%. PETS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -10.3% and -12.2%, respectively, while the SPY returned +3.9% and -0.7%, respectively.
PETS support price is $1.65 and resistance is $1.75 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PETS shares will trade within this expected range on the day.